AirSculpt Technologies, Inc. (NASDAQ: AIRS) is a medical aesthetics company specializing in minimally invasive body contouring solutions. The company’s proprietary AirSculpt® platform combines patented technology with a needle-free approach to fat removal, offering patients a streamlined procedure designed to deliver precise sculpting results with reduced pain and downtime. Utilizing a handheld device and local tumescent anesthesia, the AirSculpt® technique targets and extracts unwanted adipose tissue while preserving surrounding tissues and blood vessels.
In addition to its flagship fat-removal service, AirSculpt Technologies offers complementary treatments such as skin tightening and cellulite reduction, positioning itself as a full-service provider in the aesthetic and cosmetic surgery markets. The company partners with board-certified physicians and operates a growing network of branded studios across major U.S. metropolitan areas. Through these locations, AirSculpt provides a consistent patient experience, integrating pre-procedure consultations, in-studio interventions, and post-procedure support.
Founded in 2015 by industry pioneers Dr. Austin Santoro and Dr. Jeff Cheung, AirSculpt Technologies is headquartered in Glendale, California. Since completing its merger with a special-purpose acquisition company in 2022, the firm has focused on expanding studio footprint, advancing research and development efforts, and enhancing its proprietary instrumentation. Leadership is comprised of a multidisciplinary executive team with expertise in medical device innovation, healthcare operations, and aesthetic services.
Looking ahead, AirSculpt Technologies aims to capitalize on growing global demand for non-invasive and minimally invasive cosmetic procedures. The company’s strategic priorities include opening new branded studios, extending franchise and licensing partnerships, and investing in next-generation device enhancements. By continuously refining its technology and expanding its service portfolio, AirSculpt aspires to set new standards in patient satisfaction and safety within the aesthetic surgery industry.
AI Generated. May Contain Errors.